Ceftobiprole: the first anti-MRSA cephalosporin antibiotic.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2008 AND VI 43 AND IP 2
Results: 16
1
2
Policy watch. Drug development and regulation could be affected by limited resources at FDA.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
A review of nonpharmacologic and pharmacologic therapies for smoking cessation.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
News capsules. Treatment of type 2 diabetes with rosiglitazone associated with increased risk of cardiovascular events among older adults.
- Published in:
- 2008
- Publication type:
- Journal Article
5
News capsules. Lenalidomide plus dexamethasone demonstrates efficacy in the treatment of relapsed or refractory multiple myeloma.
- Published in:
- 2008
- Publication type:
- Journal Article
6
Drug Watch.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 84
- Publication type:
- Article
7
Drug development and regulation could be affected by limited resources at FDA.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 82
- By:
- Publication type:
- Article
8
Treatment of type 2 diabetes with rosiglitazone associated with increased risk of cardiovascular events among older adults.
- Published in:
- 2008
- Publication type:
- Case Study
9
Lenalidomide plus dexamethasone demonstrates efficacy in the treatment of relapsed or refractory multiple myeloma.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 79
- Publication type:
- Article
10
Ceftobiprole.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 66
- By:
- Publication type:
- Article
11
A review of nonpharmacologic and pharmacologic therapies for smoking cessation.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 44
- By:
- Publication type:
- Article
12
First-time generic approval.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 42
- Publication type:
- Article
13
FDA actions in brief.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 40
- Publication type:
- Article
14
New indication.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 40
- Publication type:
- Article
15
New molecular entity.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 39
- Publication type:
- Article
16
Pipeline preview.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 39
- Publication type:
- Article